In:
Blood, American Society of Hematology, Vol. 129, No. 15 ( 2017-04-13), p. 2111-2119
Kurzfassung:
Significant improvement in outcome is a reality for newly diagnosed AL amyloidosis in the past decade. Six-month mortality among transplant ineligible patients has declined since 2005.
Materialart:
Online-Ressource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood-2016-11-751628
Sprache:
Englisch
Verlag:
American Society of Hematology
Publikationsdatum:
2017
ZDB Id:
1468538-3
ZDB Id:
80069-7